Molbank
(May 2021)
Methyl 2-Amino-4-[1-(<em>tert</em>-butoxycarbonyl)azetidin-3-yl]-1,3-selenazole-5-carboxylate
Karolina Dzedulionytė,
Paulina Voznikaitė,
Aurimas Bieliauskas,
Vida Malinauskienė,
Frank A. Sløk,
Algirdas Šačkus
Affiliations
Karolina Dzedulionytė
Department of Organic Chemistry, Kaunas University of Technology, Radvilėnų pl. 19, LT-50254 Kaunas, Lithuania
Paulina Voznikaitė
Institute of Synthetic Chemistry, Kaunas University of Technology, K. Baršausko g. 59, LT-51423 Kaunas, Lithuania
Aurimas Bieliauskas
Institute of Synthetic Chemistry, Kaunas University of Technology, K. Baršausko g. 59, LT-51423 Kaunas, Lithuania
Vida Malinauskienė
Department of Organic Chemistry, Kaunas University of Technology, Radvilėnų pl. 19, LT-50254 Kaunas, Lithuania
Frank A. Sløk
Vipergen ApS, 23A Gammel Kongevej, V DK-1610 Copenhagen, Denmark
Algirdas Šačkus
Department of Organic Chemistry, Kaunas University of Technology, Radvilėnų pl. 19, LT-50254 Kaunas, Lithuania
DOI
https://doi.org/10.3390/M1207
Journal volume & issue
Vol. 2021,
no. 2
p.
M1207
Abstract
Read online
Methyl 2-amino-4-[1-(tert-butoxycarbonyl)azetidin-3-yl]-1,3-selenazole-5-carboxylate as a newly functionalized heterocyclic amino acid was obtained via [3+2] cycloaddition. The structure of the novel 1,3-selenazole was unequivocally confirmed by detailed 1H, 13C, 15N, and 77Se NMR spectroscopic experiments, HRMS and elemental analysis.
Keywords
WeChat QR code
Close